Osteotec has announced an exclusive distribution agreement with Westminster-based Highridge Medical to distribute spine surgery solutions in the UK. The partnership, effective Dec. 13, 2024, combines Osteotec’s established presence in the UK with Highridge Medical’s spinal products. This move aims to strengthen Osteotec’s spine product portfolio and enhance opportunities for both patient outcomes and market growth.
Highridge Medical offers a comprehensive range of spine products and treatments including implants, fixation systems, and biologics, backed by clinical evidence and training programs for surgeons.
The agreement adds a premium partner to Osteotec’s portfolio, aiming to enhance options for surgeons and drive increased sales and market share in the region. The partnership focuses on innovation, quality and support to meet the evolving needs of both surgeons and patients.
Rebecca Whitney, Highridge Medical CEO, said: “Osteotec’s established reputation and deep connections within the surgical community make them an ideal partner. Together, we look forward to advancing spinal care in the UK, delivering comprehensive training to empower surgeons and improve lives.”
Osteotec, headquartered in Newbury, UK, has been supplying medical devices to the NHS and private healthcare sectors since its establishment in 1993.
